H.R. 10185, Medicare Beneficiary Premium Subsidy. Quorum's AI analysis reads it as a net benefit — and names who gains.
H.R. 10185 · Net good
What it does
This bill requires the federal government to calculate a temporary discount on Medicare Part D prescription drug plan premiums for 2027, based on average premium reductions observed during a 2024–2026 demonstration project. The discount is applied directly to enrollees' premiums, with the government reimbursing insurance plans for the foregone revenue. Enrollees benefit through lower out-of-pocket costs; the government bears the cost.
The analysis names Medicare Part D enrollees (direct premium reduction) — and 1 more group — among the beneficiaries.
The trade-off
The credit is pegged to a specific demonstration project's results (July 29, 2024 announcement), making the benefit dependent on how that demonstration was designed and which plans participated—potential for variation in actual savings across regions or plan types.
Transparency scores 82%, with a medium warning level and no provisions unrelated to the bill's subject.
Who is behind it
Filed by Gus Bilirakis.
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.